معرفی
Dr. Meiling Han is an ARC DECRA Fellow (2023-2025) and Group Leader at Monash Biomedicine Discovery Institute, specializing in antimicrobial resistance research. She holds a PhD in antimicrobial systems pharmacology (2018) from Monash University. She has supervised 7 students (including 4 PhD candidates) and secured grants such as the ARC DECRA Fellowship and AINSE Early Career Research Grant. Her work focuses on bacterial membrane lipid remodelling, metabolomics, and lipidomics to combat antibiotic resistance.
Education: PhD in Antimicrobial Systems Pharmacology (Monash Institute of Pharmaceutical Science, 2018).
Research interests include bacterial lipid metabolism, antimicrobial resistance mechanisms, and drug discovery. Recent projects include investigating polymyxin resistance in Acinetobacter baumannii and Klebsiella pneumoniae using metabolomics and neutron reflectometry. She leads 8 active research projects, including studies on lipid nanoparticles targeting Gram-negative bacteria and bacterial membrane defense mechanisms.
Key achievements: Over 50 peer-reviewed publications (e.g., Nat Commun, Cell Reports), >1500 citations, and vice-chair role at the 2023 Gordon Research Seminar in Metabolomics. Awards include the Rod Rickards Fellowship and BDI Research Accelerator Program grant.
Lab activities: Han Lab focuses on lipidomics-driven antimicrobial strategies, with collaborations across institutions. She accepts PhD/Masters students in antimicrobial resistance and host-pathogen interaction research.
